In Vitro Antifungal Activity of Ibrexafungerp (SCY-078) Against Contemporary Blood Isolates From Medically Relevant Species of Candida: A European Study by Guillermo Quindós, Katherine Miranda-Cadena, Rosario San-Millán, Katyna Borroto-Esoda, Emilia Cantón, María José Linares-Sicilia, Axel Hamprecht, Isabel Montesinos, Anna Maria Tortorano, Anna Prigitano, Matxalen Vidal-García, Cristina Marcos-Arias, Andrea Guridi, Ferran Sanchez-Reus, Jesús Machuca-Bárcena, Manuel Antonio Rodríguez-Iglesias, Estrella Martín-Mazuelos, Carmen Castro-Méndez, Leyre López-Soria, Alba Ruiz-Gaitán, Marcelo Fernandez-Rivero, Damaris Lorenzo, Javier Capilla, Antonio Rezusta, Javier Pemán, Josep Guarro, Joana Pereira, Célia Pais, Orazio Romeo, Guillermo Ezpeleta, Nerea Jauregizar, David Angulo, Elena Eraso

Subjects: Get full text

Ibrexafungerp: A First-in-Class Oral Triterpenoid Glucan Synthase Inhibitor by Sabelle Jallow, Nelesh P. Govender

Subjects: Get full text

Multiresistant Fusarium Pathogens on Plants and Humans: Solutions in (from) the Antifungal Pipeline? by Al-Hatmi AMS, de Hoog GS, Meis JF

Subjects: Get full text